New phase 3b interim data from STARDUST study show majority patients with moderately to severely active Crohns Disease achieved clinical remission after two doses of STELARA

Intestinal ultrasound IUS responses were assessed and were detected as early as week 4.2 Week 16 data digital oral presentation or DOP 13 and IUS response data DOP The post New phase 3b interim data from STARDUST study show majority patients with moderatel...